NASDAQ:HALO

Halozyme Therapeutics Stock Insider Trading

etoro logo Buy HALO
*Your capital is at risk
$80.84
+3.02 (+3.88%)
At Close: Jul 23, 2026

Halozyme Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -68.58. In total, the insiders bought 721.01K and sold 251.08K HALO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-68.58
Buy 721.01K shares
Sell 251.08K shares
54% Buy Activity
Weak Negative Correlation
Buy Signal Low Confidence
Jul 01, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -68.58.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jul 08, 2026
Buy
Common Stock
M-Exempt
Torley Helen
President And CEO
CEO / President 1 923
Value: $23.2K
Jul 08, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 888
Value: $70.4K
Jul 08, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 1 035
Value: $83.0K
Jul 08, 2026
Buy
Option to Purchase Common Stock
M-Exempt
Torley Helen
President And CEO
CEO / President 1 923
Value: $23.2K
Jul 01, 2026
Sell
Common Stock
S-Sale
Connaughton Bernadette
Director
Director 625
Value: $48.3K
Jul 01, 2026
Buy
Option to Purchase Common Stock
A-Award
Ramsay David A
EVP, President, Drug Delivery
CEO / President 39 823
Value: $3.07M
Jul 01, 2026
Sell
Common Stock
S-Sale
Connaughton Bernadette
Director
Director 1 000
Value: $76.4K
Jul 01, 2026
Buy
Restricted Stock Units
A-Award
Snellgrove Darren
SVP, Chief Financial Officer
C-Suite Officer 41 554
Value: $3.20M
Jul 01, 2026
Buy
Option to Purchase Common Stock
A-Award
Snellgrove Darren
SVP, Chief Financial Officer
C-Suite Officer 127 432
Value: $9.81M
Jul 01, 2026
Buy
Restricted Stock Units
A-Award
Ramsay David A
EVP, President, Drug Delivery
CEO / President 16 232
Value: $1.25M
Jun 30, 2026
Buy
Restricted Stock Units
M-Exempt
Ramsay David A
EVP, President, Drug Delivery
CEO / President 10 000
Value: $782.7K
Jun 30, 2026
Sell
Common Stock
F-InKind
Ramsay David A
EVP, President, Drug Delivery
CEO / President 5 408
Value: $423.3K
Jun 30, 2026
Buy
Common Stock
M-Exempt
Ramsay David A
EVP, President, Drug Delivery
CEO / President 10 000
Value: $782.7K
Jun 29, 2026
Buy
Option to Purchase Common Stock
M-Exempt
Krishnan Mahesh
Director
Director 7 304
Value: $280.9K
Jun 29, 2026
Sell
Common Stock
S-Sale
Krishnan Mahesh
Director
Director 7 304
Value: $547.8K
Jun 29, 2026
Buy
Common Stock
M-Exempt
Krishnan Mahesh
Director
Director 7 304
Value: $280.9K
Jun 12, 2026
Buy
Common Stock
M-Exempt
Snyder Mark Howard
SVP, Chief Legal Officer
Officer 5 034
Value: $349.9K
Jun 12, 2026
Sell
Common Stock
F-InKind
Snyder Mark Howard
SVP, Chief Legal Officer
Officer 2 715
Value: $188.7K
Jun 12, 2026
Buy
Restricted Stock Units
M-Exempt
Snyder Mark Howard
SVP, Chief Legal Officer
Officer 5 034
Value: $349.9K
Jun 08, 2026
Buy
Common Stock
J-Other
Snellgrove Darren
Officer
Officer 0
Value: $0
Jun 03, 2026
Buy
Common Stock
M-Exempt
Torley Helen
President And CEO
CEO / President 10 000
Value: $120.7K
Jun 03, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 2 000
Value: $137.5K
Jun 03, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 6 100
Value: $425.1K
Jun 03, 2026
Buy
Option to Purchase Common Stock
M-Exempt
Torley Helen
President And CEO
CEO / President 10 000
Value: $120.7K
Jun 03, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 1 500
Value: $101.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT HALOZYME THERAPEUTICS
Halozyme Therapeutics
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules a...
GOLDEN STAR
Ticker Change Signal Date
I
INTR
$5.62
1.25% Jul 20
DHT
$17.31
4.74% Jul 13
JLL
$299.78
8.09% Jun 24
NMRK
$15.02
2.13% Jun 24
ROP
$331.60
1.54% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE